Related Experiment Video
Updated: Apr 26, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Oncogene-mediated regulation of p53 ISGylation and functions
Yi-Fu Huang1, Dmitry V Bulavin2
1Institute of Molecular and Cell Biology, Proteos, Singapore.
Abstract:
Oncogene-mediated cellular transformation is a multistep process involving activation of growth-promoting pathways as well as inactivation of tumor suppressors. We recently found that ISGylation of the p53 tumor suppressor is an important novel mechanism to control its stability. Here we identified that Isg15-dependent regulation of p53 can be enhanced by different oncogenes. We further show that the Src-mediated phosphorylation of p53 on Tyr126 and Tyr220 has a positive effect on p53 ISGylation by enhancing Herc5 binding. In turn, deletion of Isg15 results in accumulation and activation of native p53 in transformed cells thus increasing its anti-cancer activity and suppressing tumorigenesis in mice. We propose that Isg15-dependent degradation of p53 is an alternative pathway for oncogenes to regulate p53 activity, and thus is an attractive pathway for development of new anti-cancer drugs.
Insights
Oncogenes enhance the stability of the p53 tumor suppressor through ISGylation. Blocking this process boosts p53
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Oncogene activation and tumor suppressor inactivation drive cellular transformation.
- ISGylation (ISGylation) of p53 is a novel mechanism regulating its stability.
- Oncogenes can modulate p53 ISGylation.
Purpose of the Study:
- To investigate how oncogenes enhance p53 ISGylation.
- To determine the functional consequences of Isg15-dependent p53 regulation in cancer.
- To explore the therapeutic potential of targeting this pathway.
Main Methods:
- Investigated Src-mediated phosphorylation of p53.
- Assessed the effect of phosphorylation on Herc5 binding and p53 ISGylation.
- Utilized Isg15-deficient cell and mouse models.
- Evaluated p53 accumulation, activation, and anti-cancer activity.
Main Results:
- Src-mediated phosphorylation of p53 at Tyr126 and Tyr220 enhances p53 ISGylation by increasing Herc5 binding.
- Loss of Isg15 leads to p53 accumulation and activation in transformed cells.
- Isg15 deletion suppresses tumorigenesis in mice by enhancing p53's anti-cancer activity.
Conclusions:
- Isg15-dependent degradation of p53 represents an alternative oncogenic pathway to control p53 activity.
- Targeting the Isg15-p53 interaction is a promising strategy for novel anti-cancer drug development.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

